超灵敏LC-FACSeq解析急性髓系白血病细胞层级基因组
该研究利用LC-FACSeq在88例AML患者的诊断、缓解和复发阶段分析免疫表型定义亚群的克隆组成,发现信号通路突变在 putative LSC 中较少,并揭示TP53突变AML从白血病前HSC阶段逐步获得突变,且LSC池内存在遗传和功能异质性,LC-FACSeq可追踪克隆演化并指导针对MRD的靶向治疗。
要点
- DNA甲基化、转录因子和剪接体突变在各亚群间无差异,信号通路突变在 putative LSC 中较少。
- TP53突变AML从白血病前HSC阶段逐步获得突变,伴随del(17p)导致LSC池异质性。
- LC-FACSeq可追踪连续样本的克隆演化,有潜力指导针对MRD的靶向治疗。
核心结论
- 研究临床意义的小亚群细胞可增进对AML生物学的理解,并优于批量测序监测疾病演化。
研究设计与样本
- 研究纳入88例AML患者,在诊断、缓解和复发时通过LC-FACSeq对免疫表型定义的细胞亚群进行基因组和功能分析。
主要发现
- DNA甲基化通路、转录因子和剪接体机器相关突变在各细胞亚群间无差异。
- 信号通路突变在 putative LSCs 中频率较低。
- 在10例分析病例中,TP53突变AML从白血病前HSC阶段逐步获得突变,额外突变和del(17p)导致LSC池内遗传和功能异质性,亚克隆克隆潜能不同。
关键数值与推荐
- 88例AML患者中,DNA甲基化、转录因子和剪接体突变在各亚群间无差异,信号通路突变在 putative LSCs 中较少。
- 10例分析病例显示,TP53突变AML从白血病前HSC阶段逐步获得突变,额外突变和del(17p)导致LSC池异质性。
临床怎么用
- LC-FACSeq可用于追踪连续样本中的克隆演化,并可能指导针对可测量残留病的靶向治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hematopoiesis is hierarchical, and it has been postulated that acute myeloid leukemia (AML) is organized similarly with leukemia stem cells (LSCs) residing at the apex. Limited cells acquired by fluorescence activated cell sorting in tandem with targeted amplicon-based sequencing (LC-FACSeq) enables identification of mutations in small subpopulations of cells, such as LSCs. Leveraging this, we studied clonal compositions of immunophenotypically-defined compartments in AML through genomic and functional analyses at diagnosis, remission and relapse in 88 AML patients. Mutations involving DNA methylation pathways, transcription factors and spliceosomal machinery did not differ across compartments, while signaling pathway mutations were less frequent in putative LSCs. We also provide insights into TP53-mutated AML by demonstrating stepwise acquisition of mutations beginning from the preleukemic hematopoietic stem cell stage. In 10 analyzed cases, acquisition of additional mutations and del(17p) led to genetic and functional heterogeneity within the LSC pool with subclones harboring varying degrees of clonogenic potential. Finally, we use LC-FACSeq to track clonal evolution in serial samples, which can also be a powerful tool to direct targeted therapy against measurable residual disease. Therefore, studying clinically significant small subpopulations of cells can improve our understanding of AML biology and offers advantages over bulk sequencing to monitor the evolution of disease.
引用
- Saygin C, Hu E, Zhang P, et al. Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeq. Leukemia. 2021. PMID: 34021247. doi:10.1038/s41375-021-01295-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。